Protagonist Therapeutics Inc (PTGX)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	275,188	170,849	169,954	162,110	-76,659	-135,279	-131,335	-133,506	-122,826	-128,448	-132,091	-122,302	-125,551	-107,530	-81,489	-70,068	-66,150	-64,765	-73,411	-83,164
Total assets	US$ in thousands	744,725	603,857	614,629	629,276	357,951	330,016	320,466	239,858	247,928	282,174	310,512	348,296	347,695	373,175	404,232	298,072	324,468	217,320	224,980	134,901
ROA		36.95%	28.29%	27.65%	25.76%	-21.42%	-40.99%	-40.98%	-55.66%	-49.54%	-45.52%	-42.54%	-35.11%	-36.11%	-28.81%	-20.16%	-23.51%	-20.39%	-29.80%	-32.63%	-61.65%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $275,188K ÷ $744,725K
= 36.95%

Protagonist Therapeutics Inc's return on assets (ROA) experienced significant fluctuations over the past few years. The ROA was negative from March 31, 2020, to December 31, 2023, reaching its lowest point at -55.66% on March 31, 2023. This indicates that during this period, the company was not effectively generating profits from its assets.

However, the trend changed positively starting from March 31, 2024, where the ROA turned positive at 25.76% and continued to increase, reaching 36.95% by December 31, 2024. This improvement suggests that the company's profitability relative to its assets improved significantly in the latter part of 2024.

Overall, the recent positive trend in ROA indicates that Protagonist Therapeutics Inc has been more efficient in generating profits from its assets, potentially reflecting better management of resources and operations. It will be important to monitor future ROA figures to assess the company's ongoing financial performance and efficiency.